Auteur/autrice : oxeltis

https://resiconference.com Connect with Oxeltis at Resi Conference, 8-10 June 2021  #medicinalchemistry #smallmolecules #antivirals #medchemservices #networkinghttps://resiconference.com

Dr Stéphane Salamone and Dr Olivier Lavergne will be instrumental in boosting additional lab and medchem capabilities at the company Montpellier, France, November 9, 2020 – Oxeltis, a medicinal chemistry (...)

At Oxeltis, we are committed to continuing our medicinal chemistry research services during the Sars-Cov 2 outbreak, with respect to our staff’s safety and in accordance with the rules put in (...)

For the second year, Oxeltis is participating to the Medicinal Chemistry Symposium organized by the Pharmaceutical Society of Japan. Please visit us at Oxeltis booth #9 to talk about your (...)

Oxeltis is pleased to announce to its customers and R&D partners the renewal of its agreement for R&D tax credit (agrément Crédit Impôt Recherche) by the French Ministry of Higher (...)

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. Meet (...)

Retrouvez Oxeltis  aux Afssi Connexions 2019 à Lyon! contact@oxeltis.com